Anika Revenues Down $ANIK $XHS

Anika Therapeutics, Inc., a leader in products for tissue protection, healing, and repair,has announced its financial results for the first quarter of FY-2015. The results shows Revenues down from $34.0 Million to $15.5 Million, while EPS Net Income downs from $0.97 to $0.23 YoY. View the full earnings release here.

Anika Revenues Down $ANIK $XHS Read More »